November 12, 2026: What Actually Changes for Hemp Products

You bought a THCA pre-roll at a smoke shop last month. Or a 5 mg seltzer at a liquor store. Or delta-8 gummies online, shipped to a state with no dispensaries. Nobody at the counter mentioned that the federal rule those products depend on has an expiration date.

It does. November 12, 2026.

That date is not a rumor, a proposed rule, or an agency’s plan. It is written into a law that was already signed. The clock started on November 12, 2025, and it runs 365 days.

Most consumers have never heard of it. This article is the statutory text itself, in plain language, plus an honest accounting of what nobody can tell you yet.

The law, and where the date comes from

The provision is Section 781 of Public Law 119-37 — formally the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026. It was the bill that ended the government shutdown. The hemp rewrite rode along inside it.

Section 781 opens like this:

“Effective 365 days after the enactment of this Act, Section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) is amended…”

Enactment was November 12, 2025. Add 365 days and you land on November 12, 2026.

What follows is not a new ban. It is something quieter and, in practice, larger: Congress struck the old definition of “hemp” and wrote a new one. Everything the 2018 Farm Bill made possible sat on that single definition. Change the definition and the ground moves under the whole category — without the word “prohibited” appearing anywhere.

We covered the shape of this fight in our 2026 hemp and cannabis regulatory landscape explainer. This piece goes to the text.

There are three operative changes. Here they are, one at a time.

Change 1: THCA now counts toward the 0.3% limit

The new definition reads:

“The term ‘hemp’ means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent on a dry weight basis.”

Compare that to the old standard, which measured delta-9 THC only.

Why this is the change that matters most

Raw cannabis does not contain much delta-9 THC. It contains THCA — tetrahydrocannabinolic acid, the acidic precursor. THCA is not intoxicating on its own. Heat converts it. Light a joint, hit a vaporizer, or bake a tray of flower, and THCA loses a carboxyl group and becomes delta-9 THC.

So a flower that tests at 0.2% delta-9 THC and 25% THCA passes an old-standard lab test and gets you high anyway. That gap is not a technicality anyone stumbled into. It is the entire commercial basis of THCA flower, a product that is chemically indistinguishable from dispensary cannabis and was sold as federally lawful hemp.

The new text closes the gap by naming THCA directly, in parentheses, inside the definition.

The arithmetic, and what the statute leaves out

Chemists convert THCA to its THC equivalent using the ratio of the two molecules’ weights — roughly 0.877, because THCA is a slightly heavier molecule that sheds part of itself during decarboxylation.

Run that on typical flower. At 20% THCA, the THC-equivalent contribution alone is about 17.5%. The threshold is 0.3%. It is not a near miss.

Two honest caveats. First, the section quoted above does not supply a formula. It says “total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid)” and stops. How that gets calculated in a compliance test sits in testing regulation, not in this text, and I am not going to tell you a number the statute does not contain.

Second, note the reach of the phrase “and any part of that plant… and all derivatives, extracts, cannabinoids, isomers, acids, salts.” The 0.3% ceiling is not applied only to a plant in a field. It travels to extracts. A high-potency distillate is not 0.3% anything — it is mostly cannabinoid. Read plainly, concentrated extracts do not clear this bar on their own.

Change 2: Cannabinoids made outside the plant are excluded

The second change targets the semi-synthetic category. The statute excludes hemp-derived cannabinoid products containing:

“(I) cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant;

(II) cannabinoids that — (aa) are capable of being naturally produced by a Cannabis sativa L. plant; and (bb) were synthesized or manufactured outside the plant…“

Prong I covers molecules the plant simply does not make. Prong II is the one with teeth: it covers molecules the plant does make, but that were produced somewhere other than inside a plant.

That second prong retires the standard industry defense, which has always been “it occurs in nature.” The question is no longer whether a cannabinoid can exist naturally. It is where the molecule in your cartridge actually came from.

Commercial delta-8 THC is not extracted from plants in meaningful quantity. It is made by chemically converting CBD in a reaction vessel. Same for most HHC on the market. Whichever prong a given molecule falls under, a product built on benchtop isomerization has a hard time reading itself out of both.

Which cannabinoids land in which bucket is not left to argument. Section 781 also directs the FDA, within 90 days of enactment, to publish:

• a list of all cannabinoids known to be capable of being naturally produced by the plant, as reflected in peer-reviewed literature;
• a list of all tetrahydrocannabinol class cannabinoids known to occur naturally in the plant;
• a list of other cannabinoids with similar effects to — or marketed to have similar effects to — THC-class cannabinoids;
• more detail on the term “container.”

Those four lists do an enormous amount of the actual work here. They are where a molecule like THCP gets sorted. That 90-day deadline fell in February 2026. I am reporting the statutory directive, not the agency’s current output — if you need to know what those lists say today, go to FDA directly rather than trusting a summary.

One more line worth knowing, because it closes an obvious workaround. The statute also excludes intermediate hemp products “which are marketed or sold as a final product or directly to an end consumer for personal or household use.” Selling bulk material straight to the public does not convert it into something else.

Change 3: 0.4 milligrams per container

This is the provision that reshapes an entire retail category, and it is the one almost nobody has read.

The statute sets two different ceilings depending on where a product sits in the supply chain.

Intermediate hemp-derived cannabinoid products — powders, liquids, oils, anything meant to be formulated into something else — are excluded if they contain “more than 0.3 percent combined total” of total tetrahydrocannabinols and similar-effect cannabinoids.

Final products — the thing on the shelf — are excluded if they contain:

“greater than 0.4 milligrams combined total per container of — (aa) total tetrahydrocannabinols (including tetrahydrocannabinolic acid); and (bb) any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).”

Three things to notice.

It is per container, not per serving

The statute defines the term, and the definition is narrow:

“The term ‘container’ means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge.”

Innermost. Not the shipping box. And the list names a cartridge explicitly, which forecloses the argument that a vape cart is a component rather than a container.

Because the cap is per container rather than per dose, a thirty-serving bottle gets the same 0.4 mg ceiling as a single gummy. That is not an interpretation; it is what “per container” means. It puts multi-serving formats — full-spectrum tinctures, bottles of softgels, bags of gummies — under more pressure than single units, not less.

The math on beverages is not close

A hemp-derived THC seltzer in the popular low-dose range carries 5 mg per can. The can is the innermost vessel, so the can is the container.

5 mg against a 0.4 mg ceiling is more than twelve times over. Even a 2.5 mg “microdose” beverage sits at roughly six times the cap. There is no reformulation that gets a recognizably intoxicating drink under 0.4 mg — 0.4 mg is below the threshold where most people feel anything at all.

You cannot swap in a different cannabinoid

The cap is a combined total, and clause (bb) sweeps in “any other cannabinoids that have similar effects (or are marketed to have similar effects).” Note that second half. A product can be captured by how it is marketed, independent of its pharmacology. Building a drink around HHC or THCP instead of delta-9 does not route around a rule written this way.

The change	What the text says	What it plausibly reaches
Total THC standard	“total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent”	THCA flower, THCA pre-rolls, high-potency extracts
Outside-the-plant exclusion	cannabinoids “synthesized or manufactured outside the plant”	Delta-8, delta-10, HHC, THC-O, most novel cannabinoid vapes
Container cap	“greater than 0.4 milligrams combined total per container”	THC seltzers, gummies, tinctures, most edibles sold outside dispensaries

What the law leaves alone

Not everything hemp is in scope, and the exclusions are specific.

Industrial hemp is expressly included in the definition and carved out by use: stalk and fiber, whole grain, oil, cake, nut and hull, non-cannabinoid derivatives, microgreens and edible hemp leaf grown from compliant seed, research plants that never enter commerce, and seed grown to produce those materials. Rope, hempcrete, hemp hearts, and textiles are not what this section is about.

FDA-approved drugs are excluded from the term “hemp-derived cannabinoid product” — specifically drugs approved under subsection (c) or (j) of section 505 of the Federal Food, Drug, and Cosmetic Act. A prescription cannabidiol medication is regulated as a drug and is not touched by this.

State-licensed marijuana is a separate legal universe entirely. If you buy from a licensed dispensary in a legal state, your products were never federal hemp. They are governed by state law and by the Controlled Substances Act, not by Section 781. Our state-by-state guide covers that map.

CBD itself is not named. A CBD product stays inside the definition on its own terms — but it still has to clear 0.4 mg of combined total THC per container. For broad-spectrum and isolate products that is straightforward. For full-spectrum formats carrying trace THC across many servings in one bottle, it is a real question, and it is the part of this law that CBD users have heard the least about.

Now the honest part: what nobody can tell you yet

Everything above is reading. Everything below is prediction, and I am labeling it as such because the distinction is the whole point of this article.

The statute does not say “banned.” It says these things are not hemp. That is a definitional move, and the consequences flow through other laws — principally the Controlled Substances Act, which treats THC as a controlled substance except where the hemp definition carves it out. Shrink the carve-out and more material falls back under the CSA. That is the mechanism most lawyers expect. It is a reasonable reading. It is not printed in Section 781.

Enforcement is genuinely unknown. A definition changing in the Agricultural Marketing Act does not come with an enforcement budget, a lead agency, or a compliance date for existing inventory. Whether November 13, 2026 looks like coordinated action, a slow squeeze on payment processors and shipping, or very little visible change in the short term is not something the text answers. Anyone giving you a confident forecast is guessing.

States are already moving on their own timelines, in both directions. Some have banned intoxicating hemp outright; some have built regulated frameworks; some have done nothing. A federal definition sets a floor, not a ceiling — states can be stricter, and several already are. Your state’s rules may matter more to you in practice than the federal date does, especially if you cross state lines.

Litigation is likely. A multibillion-dollar industry with a date-certain deadline is a strong candidate for legal challenge. I do not know what claims will be brought or how courts will rule.

Congress can move the date. This provision arrived inside an appropriations bill. Appropriations bills come around again. An amendment, a delay, or a carve-out before November 12 is entirely possible. It has not happened as of this writing.

If that feels unsatisfying — good. That is what the evidence actually supports. Pretending otherwise is how bad legal information spreads.

This is separate from rescheduling

A quick untangling, because the two stories run together constantly.

In April 2026, DEA and DOJ issued a final rule moving marijuana from Schedule I to Schedule III — but only for products in an FDA-approved drug product, or subject to a state-issued license to manufacture, distribute, or dispense marijuana for medical purposes (91 FR 22714, effective April 28, 2026). Adult-use cannabis was not covered and remains Schedule I. A separate hearing on broader rescheduling (91 FR 22777) opened June 29, 2026, and has not concluded.

We break the split down in our Schedule III explainer, and the broader picture sits in our 2026 legalization roundup.

The point for now: rescheduling and the hemp definition are two different tracks. Nothing in the April rescheduling changes November 12. Nothing in Section 781 changes marijuana’s schedule.

What to actually do between now and November

Practical, not alarmist.

Learn your state’s rules first. For most people the state answer arrives sooner and hits harder than the federal one.

Know what you are actually buying. If a product’s legality rests on a delta-9-only measurement, that foundation has a date on it. Reading a certificate of analysis tells you what is in the package — total THC, THCA, and everything else — regardless of what the front label claims. That skill is worth having anyway, given how unreliable potency labels can be.

Do not treat “hemp-derived” as a safety signal. It never was one. It was a measurement standard. Unregulated intoxicating products have caused real harm, including pediatric emergencies from hemp-derived THC edibles and sales to minors.

If you use cannabis to sleep or manage pain, think about supply now rather than in November. A licensed dispensary in a legal state is not affected by this provision. Whether that is available to you depends entirely on where you live.

Do not assume a drug test cares about any of this. Legal status and what shows up in a urine screen are unrelated questions, and they always have been.

The part that outlasts the statute

Congress spent a page and a half of the U.S. Statutes at Large defining hemp by measurement and origin — how much total cannabinoid, produced where. Not by plant name. Not by strain. Not by the word on the jar.

The science keeps handing us that same lesson from the other direction. Two jars of the same Blue Dream can differ substantially in cannabinoid and terpene content, and the budtender recommending it may have been on the job for three weeks. What is actually in the product, and how your body responds to it, is the real information. Whether you are chasing something calming or balanced, the ratio you land on matters more than the category label.

Lawmakers and lab chemists have landed in the same place: chemistry is the thing that is real. Which is a decent argument for keeping your own record. If you track what you took, how much, and how it actually landed, you own that data no matter which products stay on the shelf. That is what the High IQ app is for.

FAQ

Is hemp illegal after November 12, 2026? No. Hemp remains legal. The definition of hemp gets narrower, and products that fall outside the new definition lose the protection the old one gave them. Industrial hemp, and CBD products under the container cap, remain inside the definition.

Will my THCA flower be illegal? The statute does not use that word. It measures total tetrahydrocannabinols including THCA against a 0.3% ceiling, and typical THCA flower is far above that. Products that fall outside the hemp definition are widely expected to be treated as controlled substances, but enforcement is not described in the text.

Can I still buy THC seltzers? Not under the federal hemp definition as written, if they contain more than 0.4 mg combined total per can. State-licensed dispensary beverages in legal states are a different legal category and are not governed by this provision. Making your own infused drinks from legally obtained cannabis is also unaffected by it.

Does this change anything about CBD? CBD is not named as excluded. But a final product still has to stay under 0.4 milligrams of combined total THC per container, which is a low bar for full-spectrum products sold in multi-serving bottles. Isolate and broad-spectrum formats are more straightforward.

Could the date change? Yes. Congress could amend or delay it, and litigation could affect it. Neither has happened as of this writing. Treat November 12, 2026 as the operative date until something official changes it.

Does this affect state-legal dispensary cannabis? No. Dispensary products in state-legal markets were never sold as federal hemp. They are governed by state law and by the Controlled Substances Act, and Section 781 does not reach them.

A necessary note

This is not legal advice. I am an educator reading a public statute, not your attorney. Cannabis and hemp law varies enormously by state, changes quickly, and the practical consequences of this provision depend on agency action and court decisions that have not happened yet. If you have a business, an inventory, a professional license, or any real exposure here, talk to a lawyer in your jurisdiction. Do not make decisions based on a blog post — including this one.

Sources

Primary statutory and regulatory text, read directly:

• Public Law 119-37, Section 781 — Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026. Enacted November 12, 2025; Section 781 effective 365 days after enactment. Amends Section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o); note at 7 U.S.C. 1639o note. Page cite 139 Stat. 558–561. Full text: govinfo.gov
• 91 FR 22714 — Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements. Department of Justice / Drug Enforcement Administration. Final rule published and effective April 28, 2026. federalregister.gov
• 91 FR 22777 — Schedules of Controlled Substances: Rescheduling of Marijuana. Notice of hearing, Docket DEA-1362. Published April 28, 2026; hearing began June 29, 2026. federalregister.gov

All quoted statutory language in this article is reproduced verbatim from the official text linked above. Where this article characterizes consequences rather than quoting text, it says so.